About ProPhase Labs, Inc. Common Stock (DE)
ProPhase Labs Inc is a diversified company that offers a range of services including diagnostic testing, genomics testing and contract manufacturing. Its operating segments include Diagnostic services and Consumer products. The Diagnostic segment provides COVID-19 diagnostic information services to a broad range of customers in the United States, including health plans, third-party payers and government organizations. The Consumer products segment is engaged in the research, development, manufacture, distribution, marketing and sale of OTC consumer healthcare products and dietary supplements in the United States and also provide personal genomics products and services.
Market Cap
$0.01B
Employees
113
Listed Since
February 1, 1995
Industry
PHARMACEUTICAL PREPARATIONS
Website
www.prophaselabs.comPhone
(215) 345-0919
Headquarters
711 STEWART AVE, SUITE 200
NEW YORK, NY 11530
CIK
0000868278